AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
110 hedge funds and large institutions have $246M invested in Accelerate Diagnostics in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
51% less call options, than puts
Call options by funds: $1.56M | Put options by funds: $3.21M
52% less capital invested
Capital invested by funds: $513M → $246M (-$267M)
Holders
110
Holding in Top 10
3
Calls
$1.56M
Puts
$3.21M
Top Buyers
| 1 | +$3.3M | |
| 2 | +$1.51M | |
| 3 | +$794K | |
| 4 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$784K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$526K |
Top Sellers
| 1 | -$3.61M | |
| 2 | -$3.47M | |
| 3 | -$2M | |
| 4 |
Morgan Stanley
New York
|
-$1.82M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.66M |